Teyi Pharmaceutical Group Co Ltd
SZSE:002728
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.87
15.8756
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Teyi Pharmaceutical Group Co Ltd stock under the Base Case scenario is 12.84 CNY. Compared to the current market price of 8.73 CNY, Teyi Pharmaceutical Group Co Ltd is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Teyi Pharmaceutical Group Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Teyi Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Teyi Pharmaceutical Group Co Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Teyi Pharmaceutical Group Co Ltd
Balance Sheet Decomposition
Teyi Pharmaceutical Group Co Ltd
Current Assets | 965.1m |
Cash & Short-Term Investments | 303.8m |
Receivables | 124.5m |
Other Current Assets | 536.8m |
Non-Current Assets | 1.4B |
Long-Term Investments | 22.9m |
PP&E | 708.3m |
Intangibles | 688.7m |
Other Non-Current Assets | 22.8m |
Current Liabilities | 544.8m |
Accounts Payable | 35.2m |
Accrued Liabilities | 13.2m |
Short-Term Debt | 477.4m |
Other Current Liabilities | 19m |
Non-Current Liabilities | 35m |
Other Non-Current Liabilities | 35m |
Earnings Waterfall
Teyi Pharmaceutical Group Co Ltd
Revenue
|
842.6m
CNY
|
Cost of Revenue
|
-445.5m
CNY
|
Gross Profit
|
397m
CNY
|
Operating Expenses
|
-282.6m
CNY
|
Operating Income
|
114.5m
CNY
|
Other Expenses
|
-10.7m
CNY
|
Net Income
|
103.7m
CNY
|
Free Cash Flow Analysis
Teyi Pharmaceutical Group Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Teyi Pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Teyi Pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Teyi Pharmaceutical Group Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Teyi Pharmaceutical Group Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Teyi Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Teyi Pharmaceutical Group Co Ltd is 14.21 CNY with a low forecast of 14.07 CNY and a high forecast of 14.63 CNY.
Dividends
Current shareholder yield for Teyi Pharmaceutical Group Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one Teyi Pharmaceutical Group Co Ltd stock under the Base Case scenario is 12.84 CNY.
Compared to the current market price of 8.73 CNY, Teyi Pharmaceutical Group Co Ltd is Undervalued by 32%.